AlzeCure Pharma AB (publ) (ALZCUR.ST)
SEK 1.17
(0.0%)
SEK 1.17
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 476 Thousand | 570 Thousand | 576 Thousand | 495 Thousand | 44.78 Million | 104 Thousand |
| Gross Profit | -476 Thousand | -570 Thousand | -576 Thousand | -495 Thousand | -44.78 Million | -104 Thousand |
| Operating Expenses | 38.26 Million | 56.56 Million | 78.14 Million | 72.02 Million | 51 Million | 36.13 Million |
| Selling, General and Administrative Expenses | 10.59 Million | 10.16 Million | 11.26 Million | 9.37 Million | 6.03 Million | 32.49 Million |
| Research and Development Expenses | 27.23 Million | 46.18 Million | 66.71 Million | 62.35 Million | 44.78 Million | 36.82 Million |
| Other Expenses | -43 Thousand | 218 Thousand | 163 Thousand | 291 Thousand | 181 Thousand | 3.64 Million |
| Cost and Expenses | 38.26 Million | 56.56 Million | 78.14 Million | 72.02 Million | 51 Million | 36.13 Million |
| Operating Income | -38.26 Million | -56.44 Million | -77.92 Million | -71.57 Million | -50.9 Million | -35.89 Million |
| Interest Expense | - | 4000.00 | 1000.00 | 1000.00 | 149 Thousand | 92 Thousand |
| Income Tax Expense | - | -203 Thousand | 1000.00 | 1000.00 | 149 Thousand | 246 Thousand |
| Earnings before Tax | -37.16 Million | -56.23 Million | -77.78 Million | -71.36 Million | -50.85 Million | -35.98 Million |
| Net Income | -37.16 Million | -56.03 Million | -77.78 Million | -71.36 Million | -51 Million | -35.98 Million |
| Earnings Per Share Basic | -0.60 | -1.17 | -1.98 | -1.82 | -1.30 | -1.52 |
| Earnings Per Share Diluted | -0.60 | -1.17 | -1.98 | -1.82 | -1.30 | -1.52 |
| Weighted Average Shares Outstanding | 61.94 Million | 47.69 Million | 39.31 Million | 39.31 Million | 39.31 Million | 23.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 62.08 Million | 47.69 Million | 39.31 Million | 39.31 Million | 39.31 Million | 23.7 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -37.86 Million | -55.66 Million | -77.2 Million | -70.87 Million | -50.56 Million | -36.03 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 69 Thousand | 109 Thousand | 476 Thousand | 110 Thousand | 109 Thousand | 125 Thousand |
| Gross Profit | -69 Thousand | -109 Thousand | -476 Thousand | -110 Thousand | -109 Thousand | -125 Thousand |
| Operating Expenses | 8.78 Million | 9.99 Million | 37.82 Million | 9.92 Million | 7.96 Million | 10.49 Million |
| Selling, General and Administrative Expenses | 2.99 Million | 2.93 Million | - | 2.98 Million | 2.33 Million | 2.57 Million |
| Research and Development Expenses | 5.78 Million | 7.01 Million | - | 6.94 Million | 5.62 Million | 7.89 Million |
| Other Expenses | -88 Thousand | - | - | - | - | - |
| Cost and Expenses | 8.85 Million | 9.99 Million | 38.3 Million | 10.03 Million | 7.96 Million | 10.49 Million |
| Operating Income | -8.85 Million | -9.99 Million | -38.3 Million | -10.03 Million | -7.96 Million | -10.49 Million |
| Interest Expense | 18 Thousand | 1000.00 | - | - | 1000.00 | 6000.00 |
| Income Tax Expense | - | 1194.00 | - | 66.18 Thousand | 315 Thousand | 292 Thousand |
| Earnings before Tax | -8.65 Million | -9.8 Million | -37.16 Million | -9.75 Million | -7.65 Million | -10.21 Million |
| Net Income | -8.65 Million | -9.8 Million | -37.16 Million | -9.75 Million | -7.65 Million | -10.21 Million |
| Earnings Per Share Basic | -0.12 | -0.14 | - | -0.16 | -0.12 | -0.16 |
| Earnings Per Share Diluted | -0.12 | -0.14 | - | -0.16 | -0.12 | -0.16 |
| Weighted Average Shares Outstanding | 69.92 Million | 70.06 Million | 65.83 Million | 62.08 Million | 62.08 Million | 62.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 69.92 Million | 70.06 Million | 65.83 Million | 62.08 Million | 62.08 Million | 62.08 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -8.78 Million | -9.69 Million | - | -9.92 Million | -7.54 Million | -10.08 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
ELBM
BYON
FCIC
HMLA
017810
FIBIH